1. Abstract Gastric Cancer (GC) is one of the most common malignancies worldwide. The incidence of GC is particularly high in most countries in East Asia, including China, where a large proportion of GC cases are diagnosed with late-stage or Advanced Gastric Cancer (AGC). Among the possibilities in treating AGC, chemotherapy has been demonstrated to …
1. Summary (Aim) The author proposes to test the effectiveness of the combined action of 1- Micronized Purified Flavonoid Fraction – MPFF associated with topical action “barrier effect” of 2 – Sucralfate (as SOS – Sucralfate Ointment with Soothing Herbs) for some of the most common anal pathological situations with two main objectives: DOI:http://dx.doi.org/10.47829/JJGH.2021.8202
1. Abstract 1.1. Purpose: We assessed the efficacy and safety of different local-regional regimens using the network metaanalysis for hepatocellular carcinoma (HCC) with portal/hepatic vein tumor thrombosis. The interested modalities included neoadjuvant three-dimensional radiotherapy(3D-CRT), postoperative intensity-modulated radiation therapy(IMRT), Postoperative transarterial chemoembolization (TACE), 3DCRT plus TACE, and Surgery alone.
1. Abstract 1.1. Background: Fistula in-ano is an abnormal chronic infected tunnel ( tract ) between the rectum or the anal canal and perianal skin usually ,with granulation tissue which connecting a primary orifice ( internal ) to a secondary one ( external) .This morbid antity represents a dilemma for both ,patients and surgeon-proctologists because …
1. Backround and Aim Pilonidal Sinus also known as pilonidal cyst dease, sacrococcygeal fistula, intergluteal pilonidal disease is, a common disease of the sacrococcygeal region affecting mosly obese and sedentary young individuals of both genders. DOI : http://dx.doi.org/10.47829/JJGH.2021.7901
1. Abstract 1.1. Aims: This review aims to provide an overview of candidate biomarkers derived from MS-based proteomics representing inflammation or fibrosis in NAFLD and ALD. DOI:http://dx.doi.org/10.47829/JJGH.2021.7502
1. Abstract Randomized controlled trials are the gold standard for eliminating bias in determining the efficacy and safety of medical products. However, the high costs, long duration, limited generalizability, and ethical or technical feasibility of RCTs have impelled investigators to look for real-world studies as alternatives.
1. Abstract Chronic hepatitis B virus (HBV) infection leads to a heavy disease burden globally, which is disproportionately high in Asia Pacific region. The currently available antiviral therapy can effectively suppress HBV replication but is not capable of eliminating the virus. Many new drugs aiming at HBV cure are under investigation in recent years, most …
1. Abstract For chronic hepatitis B (CHB) clinical trials, new challenges in the selection of the appropriate clinical endpoints were issued with the rapidly evolving concepts in designing, conducting and analyzing clinical trials.
1. Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) has become a significant health concern not only in the US but also worldwide due to the global obesity epidemic. DOI:http://dx.doi.org/10.47829/JJGH.2021.7403
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.